Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease

Parkinson's disease (PD) is one of the most common movement disorders, and currently there is no effective treatment that can slow disease progression. Preserving and enhancing DA neuron survival is increasingly regarded as the most promising therapeutic strategy for treating PD. IRX4204 is a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Bi, Weina, Zhao, Wei, Varghese, Merina, Koch, Rick J., Walker, Ruth H., Chandraratna, Roshantha A., Sanders, Martin E., Janesick, Amanda, Blumberg, Bruce, Ward, Libby, Ho, Lap, Pasinetti, Giulio M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884932/
https://www.ncbi.nlm.nih.gov/pubmed/26862735
http://dx.doi.org/10.18632/oncotarget.7191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884932/
https://www.ncbi.nlm.nih.gov/pubmed/26862735
http://dx.doi.org/10.18632/oncotarget.7191

Ejemplares similares